Cardiovascular DiseasesNCT03385122
Environment and Cardiovascular Disease: The Corinthia Study
An observational study of Cardiovascular Diseases, run by University of Athens at 2 sites in Greece.
Trial summary
Environmental factors constitute an important but underappreciated risk factor towards the development and progression of cardiovascular disease (CVD). Environmental exposure in variable pollutants is implicated in the derangement or propagation of adverse pathophysiological processes linked with atherosclerosis… Read more about this study
- Who is it for?
- Ages 40 years and olderHealthy volunteers can take part
- Conditions the study is for
- Cardiovascular Diseases
- How many people
- 2,500 participants
- Where
- 2 sitesGreece
- Study dates
- 20 Oct 2015to 31 Dec 2030
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: We plan to recruit individuals living in three different areas according to environmental pollution i. Subjects living in areas with no evidence of soil/ground or air pollution ii. Subjects living in areas with air pollution iii. Subjects living in areas with soil/ground pollution
Who may be able to join
- Inhabitants of Corinthia Region
Who cannot join
- Inability and unwillingness to obtain informed consent
- Individuals less than 40 years of age
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Greece2 sites, 2 recruiting
- Recruiting
1st Cardiology Department, Hippokration General Hospital
Athens, Attica, 11528
Manina Anastasopoulou, +2132088026, manastas@med.uoa.gr
- Recruiting
Hippokration Hospital, First Cardiology Clinic
Athens, 11528
Evangelos Oikonomou, MD
Dimitris Tousoulis, MD, PhD, +2132088026, manastas@med.uoa.gr
About this study
Official title: Environmental Pollution and Health of Corinth Region. Corinthia Study
Environmental factors constitute an important but underappreciated risk factor towards the development and progression of cardiovascular disease (CVD). Environmental exposure in variable pollutants is implicated in the derangement or propagation of adverse pathophysiological processes linked with atherosclerosis, including genetic, hemodynamic, metabolic, oxidative and inflammation parameters. However no data exists concerning environmental pollution in rural or semi-rural areas. Therefore the purpose of the "Corinthia" study is to examine the impact of environmental pollution in indices of cardiovascular morbidity and mortality in a cross-sectional and longitudinal design. Corinthia study began in October 2015 and is planned to recruit 2400 individuals from different regions of Corinthia country with different environmental exposure to pollutants and different patterns of soil-ground and/or air pollution until September 2018. Baseline measurements will include lifestyle measurements, anthropometric characteristics and a comprehensive cardiovascular examination. The follow-up is planned to extent, prospectively, up to 10 years and this study is anticipated to provide valuable data on the distinct impact of soil and air pollution in early markers of atherosclerosis and cardiovascular disease and in the overall impact of environment pollution to cardiovascular morbidity and mortality.
Read the detailed description
Introduction
Despite major advances in cardiovascular (CV) medicine during the last decades, deaths and morbidity from cardiovascular diseases (CVD) are increasing globally [1, 2]. It seems that population aging and population growth balances out the decline in age-specific death rates from CVD that could be attributed to more effective prevention and treatment strategies [2].
Interestingly, the progress in confronting CVD is evident around the world but notably heterogeneous. Regions with the fastest growing population dynamics experienced relative increase in CV deaths in line with global trends. In contrast, developed regions reported no detectable change or little decrease in CV mortality as rapid aging of the population offsets the declines in age-specific death rates [3]. Residual CV risk beyond traditional risk factors should be reassessed and further explored in the quest of new underlying mechanisms that could provide the substrate for innovative preventive interventions and therapeutic goals.
Under this prism, environmental factors constitute an important but underappreciated risk factor towards the development and progression of CVD [4]. Environmental exposure in variable pollutants is implicated in the derangement or propagation of adverse pathophysiological processes linked with atherosclerosis, including genetic, hemodynamic, metabolic, oxidative and inflammation parameters [4]. Recent studies suggest that chronic environmental stress is an important determinant of CVD risk, even below current regulatory standards for exposure levels [4, 5].
One of the most important studies in the field of environmental cardiology, the Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air) investigated the association between long-term air pollution exposure and the progression of subclinical atherosclerosis and the incidence of CVD at an urban dwelling population [6]. However no data exists concerning environmental pollution in rural or semi-rural areas. Therefore the purpose of the "Corinthia" study is to examine the impact of environmental pollution in indices of CV morbidity and mortality in a cross-sectional and longitudinal design.
Rational of the study National-based data for Greece concerning environment pollution and CVD morbidity and mortality are markedly scarce. Research activity has focused on soil and groundwater anthropogenic contamination in river basin of heavy polluted industrialized areas but without reporting associations with CVD [7]. Moreover, certain prospective or retrospective studies have examined the association of long-term exposure to air pollution with CVD morbidity in urban population [8, 9]. The region of Corinth has rural or semi-rural areas with high exposure to soil and air contamination in distinct territories-patterns. The investigators hypothesized that long term exposure to environmental pollutants mediates detrimental epigenetic, oxidative, inflammatory and pro-atherogenic effects that could accelerate the progress and the severity of CVD as well as the quality of life and the overall morbidity and mortality. Therefore, the investigators sought to investigate in a cross sectional and longitudinal design the impact of different type of environmental pollution in indices of subclinical atherosclerosis, on rates of CV morbidity and mortality and on CVD risk.
Hypothesis of the study I. The primary hypothesis of the study is that individual exposed to different environmental pollutants have increased rate of all-cause mortality.
II. The secondary hypothesis of the study is that individuals exposed to different environmental pollutants have increased rate of CV mortality and increased incidence of non-fatal CVD (i.e. acute coronary syndromes, peripheral aortic disease, cerebrovascular disease).
III. Additional hypothesis of the study is that:
- Individuals exposed to different environmental pollutants present an adverse cardiometabolic profile in terms of surrogate markers of early atherosclerosis and oxidative stress
- Environmental pollution affects adversely the quality of life in exposed subjects
- Environmental pollution confers epigenetic alterations (telomere shortening, microRNAs mobilization and circulation) in subjects exposed to different pollutants
Experimental details and design of the Corinthia study The present study began at October 2015 and is planned to recruit 1500 individuals from different regions of Corinth with different environmental exposure to pollutants and different patterns of soil-ground and/or air pollution until December 2016.
The investigators plan to recruit individuals living in three different areas according to environmental pollution (Figure 1):
- Subjects living in areas with no evidence of soil/ground or air pollution ii. Subjects living in areas with air pollution iii. Subjects living in areas with soil/ground pollution Residents of the selected regions who are not planning to move within the next 10 years will be approached. An acceptance rate of participation of approximately 80% of those eligible subjects is anticipated. Exclusion criteria for the study would be
- Inability and unwillingness to obtain informed consent
- Individuals less than 40 years of age The recruitment into Corinthia study will be community-based, with an emphasis on balancing recruitment across the three areas, census blocks, age categories (per decades) and gender. The sampling frame will implement information from the latest national Census and will proceed along geographic boundaries. As sampling unit we will use each household, with a goal of including no more than 2 eligible participants from different households per census block. Initial contact will be performed by telephone or door-to-door. Telephone recruitment will be based on a list built from the specified geographic boundaries. Initial contact included a screening questionnaire and household enumeration of all eligible persons. The recruitment goal is 500 participants from each of the three areas of interest. During this period the research team will communicate with the local authorities and with health services in the areas of research in order to organize the volunteering selection of the participants in each area. Responsibility of the research team is also the organization of the places where field research will take place. Pilot measurements will take place and accordingly the research team will estimate the validity of the tests, and will calculate variability coefficients of the tests.
The first 24 months will be devoted to recruitment (October 2015- September 2018).
Quality Control and repeatability of measures The research fellow recruited for the study will perform all vascular and anthropometric measurements. The research fellow will undergo a 2 month training and accreditation for these measurements. Echocardiographic measurements will be performed by the same trained cardiac physiologist.
Study Measurements Baseline measurements for participants in the "Corinthia" Study will include parameters affecting the everyday lifestyle such as smoking habits, physical activity and diet. Anthropometric (height, weight, waist circumference) socio-economic and lifestyle characteristics (marital status, educational level, economic and professional status), as well as, family history and history of cardiovascular risk factors and diseases will be recorded. The investigators also planning to identify the psychological state of individuals (using a valid Depression Scale ZUNG) and participants mental status (MMSE-Mini Mental State Examination). We will record the presence and the treatment in use, if any, of hypertension, diabetes mellitus and hypercholesterolemia. Subjects will be submitted to a full cardiac examination, including physical examination, electrocardiography, echocardiography (Evaluation of left ventricle ejection fraction, of left ventricle dimensions, evaluation of valvular function, of transmittal flow pattern, of right ventricle systolic pressure, of aortic distensibility etc.), blood pressure measurements, arterial wall properties measurement with non-invasive estimation of pulse wave velocity and estimation of atherosclerotic burden with evaluation of carotid intima media thickens and of atherosclerotic plaques in carotid arteries. Peripheral blood samples will be gathered for DNA analysis, routine biochemical tests and measurement of inflammatory markers and markers of oxidative stress. Subsequent examinations, which will include repetitions of certain baseline measurements as well as new measures, will be scheduled at approximately adjacent 2-year intervals.
Selection of regions-Environmental measurements Data on soil/ground contamination with pollutants (pesticides, fertilizers etc) and of air pollution from industrial gasses and exposures will be provided from records and measurements of the Faculty of Geology and Geoenvironment and the faculty of Environmental Physics of the National and Kapodistrian University of Athens.
Follow-up The study investigators will prospectively perform the 5 and 10-year follow-up about participants': (a) Vital status (death from any cause or due to CVD), (b) development of coronary heart disease (CHD) (i.e., myocardial infarction, angina pectoris, other identified forms of ischemia, heart failure of different types, and chronic arrhythmias) and (c) development of cerebrovascular disease.
With an anticipated loss to follow-up of approximately~15% [10] the ten year follow up data are expected to decipher the effect of long term exposure to pollution on overall and cardiovascular mortality and morbidity as well as on interim endpoints of surrogate markers of subclinical atherosclerosis. Respectively, with a type I error predefined to 0.05 and all considered to be 2-tailed, a sample size of 1500 subjects would yield adequate power (>80%) to detect a 1.5- fold change in Hazzard ratio per area-group change in the aforementioned index variable towards the secondary endpoint (all-cause mortality) taking into account an event rate of 6%, a follow up period of minimum 60 months and an anticipated loss to follow up of less than 15%. Type I error was predefined at 0.05 and all tests were considered to be 2-tailed.
Conclusion The Corinthia study is an epidemiological study of Environmental importance with a cross-sectional and prospective longitudinal design planning to provide data on the distinct impact of soil and air pollution in indices of cardiovascular morbidity and mortality and in the overall health status of a rural or semi-rural population of the Greek country.
- Conditions
- Cardiovascular Diseases
- Keywords
- Cardiovascular disease
- Medical subject headings
- Cardiovascular Diseases
What is being measured
The primary outcome is the main question the study is designed to answer.
Major adverse cardiovascular events
Cardiovascular death, non fatal acute myocardial infarction, non fatal stroke
Measured: 15 Years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Dec 2017
- Study start20 Oct 2015
- Primary completion30 Sep 2018 (estimated)
- Study completion31 Dec 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Cardiovascular DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Prospective
- Enrolment
- 2,500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Athens
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dimitris Tousoulis, National and Kapodistrian University of Athens
- Investigators
- Dimitris Tousoulis, Study chair, National and Kapodistrian University of Athens, Greece, First Cardiology Clinic, Hippokratio Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03385122
- Sponsor's protocol ID
- Corinthia
- Status last verified
- Dec 2017
- First submitted
- 20 Nov 2017
- Last updated
- 28 Dec 2017
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Oikonomou E, Lazaros G, Georgiopoulos G, Christoforatou E, Papamikroulis GA, Vogiatzi G, Chasikidis C, Zacharia E, Giannaki A, Bourouki E, Mavratzas T, Stofa E, Papakonstantinou M, Tousouli M, Tousoulis D. Environment and cardiovascular disease: rationale of the Corinthia study. Hellenic J Cardiol. 2016 May-Jun;57(3):194-197. doi: 10.1016/j.hjc.2016.06.001. Epub 2016 Jun 23.
PubMed 27451913
Study at a glance
From the registry record, last updated by the sponsor on 28 Dec 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Environmental Pollution and Health of Corinth Region. Corinthia Study
- ClinicalTrials.gov ID
- NCT03385122
- Acronym / sponsor ID
- Corinthia
- Conditions
- Cardiovascular Diseases
- Keywords
- Cardiovascular disease
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 2,500 participants (estimated)
- Lead sponsor
- University of AthensUniversity, hospital or other
- Study start
- 20 Oct 2015 (actual)
- Primary completion
- 30 Sep 2018 (estimated)
- Study completion
- 31 Dec 2030 (estimated)
- First posted
- 28 Dec 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Environmental factors constitute an important but underappreciated risk factor towards the development and progression of cardiovascular disease (CVD). Environmental exposure in variable pollutants is implicated in the derangement or propagation of adverse pathophysiological processes linked with atherosclerosis, including genetic, hemodynamic, metabolic, oxidative and inflammation parameters. However no data exists concerning environmental pollution in rural or semi-rural areas. Therefore the purpose of the "Corinthia" study is to examine the impact of environmental pollution in indices of cardiovascular morbidity and mortality in a cross-sectional and longitudinal design. Corinthia study began in October 2015 and is planned to recruit 2400 individuals from different regions of Corinthia country with different environmental exposure to pollutants and different patterns of soil-ground and/or air pollution until September 2018. Baseline measurements will include lifestyle measurements, anthropometric characteristics and a comprehensive cardiovascular examination. The follow-up is planned to extent, prospectively, up to 10 years and this study is anticipated to provide valuable data on the distinct impact of soil and air pollution in early markers of atherosclerosis and cardiovascular disease and in the overall impact of environment pollution to cardiovascular morbidity and mortality.
Detailed description
Introduction
Despite major advances in cardiovascular (CV) medicine during the last decades, deaths and morbidity from cardiovascular diseases (CVD) are increasing globally [1, 2]. It seems that population aging and population growth balances out the decline in age-specific death rates from CVD that could be attributed to more effective prevention and treatment strategies [2].
Interestingly, the progress in confronting CVD is evident around the world but notably heterogeneous. Regions with the fastest growing population dynamics experienced relative increase in CV deaths in line with global trends. In contrast, developed regions reported no detectable change or little decrease in CV mortality as rapid aging of the population offsets the declines in age-specific death rates [3]. Residual CV risk beyond traditional risk factors should be reassessed and further explored in the quest of new underlying mechanisms that could provide the substrate for innovative preventive interventions and therapeutic goals.
Under this prism, environmental factors constitute an important but underappreciated risk factor towards the development and progression of CVD [4]. Environmental exposure in variable pollutants is implicated in the derangement or propagation of adverse pathophysiological processes linked with atherosclerosis, including genetic, hemodynamic, metabolic, oxidative and inflammation parameters [4]. Recent studies suggest that chronic environmental stress is an important determinant of CVD risk, even below current regulatory standards for exposure levels [4, 5].
One of the most important studies in the field of environmental cardiology, the Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air) investigated the association between long-term air pollution exposure and the progression of subclinical atherosclerosis and the incidence of CVD at an urban dwelling population [6]. However no data exists concerning environmental pollution in rural or semi-rural areas. Therefore the purpose of the "Corinthia" study is to examine the impact of environmental pollution in indices of CV morbidity and mortality in a cross-sectional and longitudinal design.
Rational of the study National-based data for Greece concerning environment pollution and CVD morbidity and mortality are markedly scarce. Research activity has focused on soil and groundwater anthropogenic contamination in river basin of heavy polluted industrialized areas but without reporting associations with CVD [7]. Moreover, certain prospective or retrospective studies have examined the association of long-term exposure to air pollution with CVD morbidity in urban population [8, 9]. The region of Corinth has rural or semi-rural areas with high exposure to soil and air contamination in distinct territories-patterns. The investigators hypothesized that long term exposure to environmental pollutants mediates detrimental epigenetic, oxidative, inflammatory and pro-atherogenic effects that could accelerate the progress and the severity of CVD as well as the quality of life and the overall morbidity and mortality. Therefore, the investigators sought to investigate in a cross sectional and longitudinal design the impact of different type of environmental pollution in indices of subclinical atherosclerosis, on rates of CV morbidity and mortality and on CVD risk.
Hypothesis of the study I. The primary hypothesis of the study is that individual exposed to different environmental pollutants have increased rate of all-cause mortality.
II. The secondary hypothesis of the study is that individuals exposed to different environmental pollutants have increased rate of CV mortality and increased incidence of non-fatal CVD (i.e. acute coronary syndromes, peripheral aortic disease, cerebrovascular disease).
III. Additional hypothesis of the study is that:
- Individuals exposed to different environmental pollutants present an adverse cardiometabolic profile in terms of surrogate markers of early atherosclerosis and oxidative stress
- Environmental pollution affects adversely the quality of life in exposed subjects
- Environmental pollution confers epigenetic alterations (telomere shortening, microRNAs mobilization and circulation) in subjects exposed to different pollutants
Experimental details and design of the Corinthia study The present study began at October 2015 and is planned to recruit 1500 individuals from different regions of Corinth with different environmental exposure to pollutants and different patterns of soil-ground and/or air pollution until December 2016.
The investigators plan to recruit individuals living in three different areas according to environmental pollution (Figure 1):
- Subjects living in areas with no evidence of soil/ground or air pollution ii. Subjects living in areas with air pollution iii. Subjects living in areas with soil/ground pollution Residents of the selected regions who are not planning to move within the next 10 years will be approached. An acceptance rate of participation of approximately 80% of those eligible subjects is anticipated. Exclusion criteria for the study would be
- Inability and unwillingness to obtain informed consent
- Individuals less than 40 years of age The recruitment into Corinthia study will be community-based, with an emphasis on balancing recruitment across the three areas, census blocks, age categories (per decades) and gender. The sampling frame will implement information from the latest national Census and will proceed along geographic boundaries. As sampling unit we will use each household, with a goal of including no more than 2 eligible participants from different households per census block. Initial contact will be performed by telephone or door-to-door. Telephone recruitment will be based on a list built from the specified geographic boundaries. Initial contact included a screening questionnaire and household enumeration of all eligible persons. The recruitment goal is 500 participants from each of the three areas of interest. During this period the research team will communicate with the local authorities and with health services in the areas of research in order to organize the volunteering selection of the participants in each area. Responsibility of the research team is also the organization of the places where field research will take place. Pilot measurements will take place and accordingly the research team will estimate the validity of the tests, and will calculate variability coefficients of the tests.
The first 24 months will be devoted to recruitment (October 2015- September 2018).
Quality Control and repeatability of measures The research fellow recruited for the study will perform all vascular and anthropometric measurements. The research fellow will undergo a 2 month training and accreditation for these measurements. Echocardiographic measurements will be performed by the same trained cardiac physiologist.
Study Measurements Baseline measurements for participants in the "Corinthia" Study will include parameters affecting the everyday lifestyle such as smoking habits, physical activity and diet. Anthropometric (height, weight, waist circumference) socio-economic and lifestyle characteristics (marital status, educational level, economic and professional status), as well as, family history and history of cardiovascular risk factors and diseases will be recorded. The investigators also planning to identify the psychological state of individuals (using a valid Depression Scale ZUNG) and participants mental status (MMSE-Mini Mental State Examination). We will record the presence and the treatment in use, if any, of hypertension, diabetes mellitus and hypercholesterolemia. Subjects will be submitted to a full cardiac examination, including physical examination, electrocardiography, echocardiography (Evaluation of left ventricle ejection fraction, of left ventricle dimensions, evaluation of valvular function, of transmittal flow pattern, of right ventricle systolic pressure, of aortic distensibility etc.), blood pressure measurements, arterial wall properties measurement with non-invasive estimation of pulse wave velocity and estimation of atherosclerotic burden with evaluation of carotid intima media thickens and of atherosclerotic plaques in carotid arteries. Peripheral blood samples will be gathered for DNA analysis, routine biochemical tests and measurement of inflammatory markers and markers of oxidative stress. Subsequent examinations, which will include repetitions of certain baseline measurements as well as new measures, will be scheduled at approximately adjacent 2-year intervals.
Selection of regions-Environmental measurements Data on soil/ground contamination with pollutants (pesticides, fertilizers etc) and of air pollution from industrial gasses and exposures will be provided from records and measurements of the Faculty of Geology and Geoenvironment and the faculty of Environmental Physics of the National and Kapodistrian University of Athens.
Follow-up The study investigators will prospectively perform the 5 and 10-year follow-up about participants': (a) Vital status (death from any cause or due to CVD), (b) development of coronary heart disease (CHD) (i.e., myocardial infarction, angina pectoris, other identified forms of ischemia, heart failure of different types, and chronic arrhythmias) and (c) development of cerebrovascular disease.
With an anticipated loss to follow-up of approximately~15% [10] the ten year follow up data are expected to decipher the effect of long term exposure to pollution on overall and cardiovascular mortality and morbidity as well as on interim endpoints of surrogate markers of subclinical atherosclerosis. Respectively, with a type I error predefined to 0.05 and all considered to be 2-tailed, a sample size of 1500 subjects would yield adequate power (>80%) to detect a 1.5- fold change in Hazzard ratio per area-group change in the aforementioned index variable towards the secondary endpoint (all-cause mortality) taking into account an event rate of 6%, a follow up period of minimum 60 months and an anticipated loss to follow up of less than 15%. Type I error was predefined at 0.05 and all tests were considered to be 2-tailed.
Conclusion The Corinthia study is an epidemiological study of Environmental importance with a cross-sectional and prospective longitudinal design planning to provide data on the distinct impact of soil and air pollution in indices of cardiovascular morbidity and mortality and in the overall health status of a rural or semi-rural population of the Greek country.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Prospective
Who may qualify
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- We plan to recruit individuals living in three different areas according to environmental pollution i. Subjects living in areas with no evidence of soil/ground or air pollution ii. Subjects living in areas with air pollution iii. Subjects living in areas with soil/ground pollution
Key inclusion criteria (1 listed)
- Inhabitants of Corinthia Region
Key exclusion criteria (2 listed)
- Inability and unwillingness to obtain informed consent
- Individuals less than 40 years of age
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Major adverse cardiovascular events
Time frame: 15 Years
Cardiovascular death, non fatal acute myocardial infarction, non fatal stroke
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Dec 2017.
- Background: PubMed 27451913Oikonomou E, Lazaros G, Georgiopoulos G, Christoforatou E, Papamikroulis GA, Vogiatzi G, Chasikidis C, Zacharia E, Giannaki A, Bourouki E, Mavratzas T, Stofa E, Papakonstantinou M, Tousouli M, Tousoulis D. Environment and cardiovascular disease: rationale of the Corinthia study. Hellenic J Cardiol. 2016 May-Jun;57(3):194-197. doi: 10.1016/j.hjc.2016.06.001. Epub 2016 Jun 23.
- Individual participant dataSharing planned: Undecided
Related trials for Cardiovascular Diseases
Recruiting
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Regurgitation
Not yet recruiting
Effect of Propionic Acid Supplementation on Endothelial Function
Cardiovascular Diseases, Endothelial Dysfunction
Recruiting
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
Cardiovascular Diseases, Myocardial Ischemia
Recruiting
Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Atherosclerosis Cardiovascular Disease
Recruiting
Vasopressor Agents in Pulmonary Hypertension Crisis
Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Dimitris Tousoulis study chair
National and Kapodistrian University of Athens, Greece, First Cardiology Clinic, Hippokratio Hospital
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cardiovascular Diseases, run by University of Athens at 2 sites in Greece.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 28 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Evangelos Oikonomou (00306947701299, boikono@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Major adverse cardiovascular events (time frame: 15 Years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03385122, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Dec 2017; AzTrials last refreshed its copy on 1 Nov 2026.